Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cystic fibrosis: A changing landscape.

The Nurse practitioner - 1 Sept 2021

Wendekier Camille, Wendekier-Raybuck Katheryn

Abstract excerpt

ABSTRACT: Cystic fibrosis is an autosomal recessive genetic disorder that causes a lifetime of debilitating and potentially fatal complications affecting the lungs and other organ systems. Over 1,700 gene mutations that cause this rare disorder have been identified. This article describes the current treatment landscape for adults with CF, including the 2019 FDA approval of a breakthrough triple-drug combination...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator
Share to Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Quality of Life

Source

Identifiers

PMID: 34424887
DOI: 10.1097/01.NPR.0000769756.82495.f3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cystic fibrosis: A changing landscape.PMID 34424887Read ↗

A new era for people with cystic fibrosis.Semantic proximity Read ↗

Advances in the diagnosis and treatment of cystic fibrosis.Semantic proximity Read ↗

Cystic Fibrosis and Its Management Through Established and Emerging Therapies.Semantic proximity Read ↗

Progress towards next-generation therapeutics for cystic fibrosis.Semantic proximity Read ↗

State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators and Triple-Combination TherapySemantic proximity Read ↗

An update on new and emerging therapies for cystic fibrosis.Semantic proximity Read ↗

Cystic fibrosis year in review 2021.Semantic proximity Read ↗

Cystic Fibrosis: A Review.Semantic proximity Read ↗

Review of Rapid Advances in Cystic Fibrosis.Semantic proximity Read ↗

Therapeutics development for cystic fibrosis: a successful model for a multisystem genetic disease.Semantic proximity Read ↗

Cystic fibrosis: an overview.Semantic proximity Read ↗

Advances in the Cystic Fibrosis Drug Development PipelineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.